Pancreatic Cancer Therapy
The Pancreatic Cancer Therapy service at the University of Maryland
Greenebaum Comprehensive Cancer Center (UMGCCC) offers a highly specialized, multidisciplinary approach
to the evaluation, diagnosis and treatment of patients with pancreatic cancer.
Our team consists of specialists who are nationally recognized experts in pancreas
cancer and lead scientific efforts to develop new and more effective therapies
that are offering hope to more and more patients each year. They meet weekly
to review each patient's case and develop the best possible treatment plan.
Our Pancreatic Cancer Therapy service provides:
- the experience and knowledge of a complete team of GI cancer experts
- access to the latest research and clinical trials in new drugs and combination
- cutting-edge technology, including Trilogy radiation therapy and state-of-the-art clinical and surgical facilities
Our patients receive the most comprehensive and effective treatment available
anywhere. UMGCCC was one of the first centers in the nation to be recognized by The National Pancreas Foundation (NPF) as an NPF Center for our expertise in treating pancreatic cancer.
Immediate Access to Cancer Surgeons
We place a high priority on providing patients with immediate access to our nationally renowned pancreas cancer specialists. To see a surgical oncology
specialist for a consultation within two business days, please call our Patient
Referral Office coordinator at 410-328-7904. (See also: Immediate Access to Cancer Experts.)
About Pancreatic Cancer
Each year, approximately 30,000 people are diagnosed with pancreatic cancer
in the United States. Most of these are people over the age of 50 with no family
history of the disease. Because its symptoms are not specific and no screening
test is currently available, pancreatic cancer is often not diagnosed until
it is at a fairly advanced stage. Aggressive treatment, with a combination of
surgery to remove all or part of the pancreas followed by radiation and/or chemotherapy,
offers the best outcome for patients.
Our Pancreatic Cancer Expertise